Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Highlights connexins as potential therapeutic targets in arrhythmias and atherosclerosis; leaves open clinical translation of gap junction modulators.
Nicholas J. Severs (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: